Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 Diabetes Mellitusukmlamrcgp aktpanemrcp part 1prescribing safety assessment

A 55-year-old woman with type 2 diabetes mellitus and hypertension presents for review. Her latest HbA1c is 62 mmol/mol despite maximum tolerated doses of metformin and gliclazide. Her BMI is 32 kg/m² and eGFR is 70 mL/min/1.73m². According to NICE NG28, what is the most appropriate next agent to add?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.